- COVID-19-Related Healthcare Fraud and Anti-Kickback Enforcement Focuses on Laboratory Testing
- While the U.S. Department of Justice (DOJ) has identified and pursued a variety of fraud schemes and activities related to COVID-19 (such as sales of fake testing kits and PPE, price gouging, and fraudulent offers for free COVID-19 testing in order to obtain Medicare beneficiary information that is used to submit false medical claims), several recent cases involving laboratory testing demonstrate that this is a key area of healthcare fraud and anti-kickback enforcement during the pandemic
- HIPAA Updates
- OCR's HIPAA guidance for healthcare providers during the COVID-19 pandemic
- HHS's extension of its Public Health Emergency
- Detailed reporting instructions for recipients of Provider Relief Funds (PRF) will be released on August 17, 2020
- Substance Abuse and Mental Health Services Administration (SAMHSA) announced the adoption of the revised Confidentiality of Substance Use Disorder Patient Records regulation, 42 CFR Part 2
- Department of Justice updated its guidance regarding evaluation of corporate compliance programs
- OCR resolved two religious freedom complaints related to COVID-19
Health care law (including regulatory and compliance issues, public health law, medical ethics, and life sciences), with digressions into constitutional law, statutory interpretation, poetry, and other things that matter
Thursday, July 30, 2020
Haynes and Boone "Health Law Vitals": Almost All COVID-19 Almost All the Time
New issue of the firm's health-law newsletter includes the following:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment